cost of tirzepatide for weight loss average in 2026: Is It Worth It vs Bariatric Surgery? What Is the Average Price – Weight Loss Shots | Cordova

One thing we know by now is losing weight can be challenging

In Phase 3 studies: Participants without diabetes taking orforglipron lost approximately 9% to 10% of body weight over roughly 36 to 40 weeks Participants with type 2 diabetes generally lost around 7% to 8% By comparison, Wegovy's landmark STEP trials reported approximately 14.9% average weight loss over 68 weeks

A single mild overdose is unlikely to cause serious harm but should be documented

When the body loses weight quickly, it can redirect resources away from hair growth, leading to a temporary condition called telogen effluvium

The metabolic effects on GLP-1 and insulin response of decaffeinated GTE in humans warrant continued investigation